AbbVie is a big company that makes medicine. Some people are buying and selling parts of this company called options. Options can make more money, but also lose more money. People who trade options need to be careful and learn a lot about it. A website called Benzinga Pro helps them by giving updates on what other people are doing with their options. Read from source...

- The article does not provide any clear context or purpose for decoding AbbVie's options activity. It is vague and lacks a coherent structure that would guide the reader through the main points and arguments of the analysis.
- The article uses ambiguous terms like "the big picture" without defining what they mean or how they relate to AbbVie's options activity. This creates confusion and misunderstanding for the reader who might expect a more comprehensive and holistic view of the company and its prospects.
- The article relies heavily on RSI indicators, which are not suitable for Options trading. RSI is a momentum indicator that measures the strength of a stock's price action based on the ratio of advancing issues to declining issues. It does not take into account the underlying volatility or implied volatility of the options contracts, which are crucial factors for Options traders. Therefore, using RSI indicators to analyze AbbVie's options activity is misleading and inaccurate.
- The article contradicts itself by stating that "options are a riskier asset compared to just trading the stock" but then implies that they have higher profit potential. This creates a false dichotomy and oversimplifies the nature of Options trading, which involves balancing risks and rewards based on various factors such as strike price, expiration date, time decay, volatility, and dividend yield.
- The article promotes Benzinga Pro as a solution for staying updated on the latest options trades for AbbVie, without disclosing that it is a paid service or providing any evidence of its effectiveness or credibility. This creates a conflict of interest and undermines the objectivity and trustworthiness of the article.

Based on my analysis of AbbVie's options activity, I have developed the following comprehensive investment recommendations and risks for interested parties. Please note that these are not guarantees or certainties, but rather probabilities based on current market conditions and historical trends.